A team from the Duke Global Health Institute and Duke-Margolis were contracted by Global Health Technologies Coalition to conduct a formal exploration regarding how the US government could improve its support for global health research and product development. Although policy reports to date had generated recommendations which appear year after year, there had been no formal exploration, to the best of our knowledge, of stakeholder perspectives on what was working, not working, how feasible the policy options were, how recommended solutions would be implemented, or general thoughts on innovative solutions.
This project went “beyond the funding question” to identify who makes decisions about global health R&D investment, where decisions get made, when they happen in the legislative calendar, what the “levers” might be for those who wish to advocate for increased funding, and assess the “appetite” for change. At the end of this inquiry, we created a policy map that detailed the decision-making process to inform a more educated advocacy approach. The direction of this report potentially supports an overarching US Government Global Health product research and development strategy across various stakeholders that maximizes the US Government investment in pursuit of better health outcomes for low- and middle-income countries.
Mark B. McClellan
Director, Duke-Robert J. Margolis, MD, Center for Health Policy
Robert J. Margolis MD Professor of Business, Medicine and Health Policy
Michael Merson, MD
Founding Director of the Duke Global Health Institute
Wolfgang Joklik Professor of Global Health
Vice President and Vice Provost of Global Strategy
Gavin Yamey MD, MPH
Professor of the Practice of Global Health and Sanford School of Public Policy
David Ridley, PhD
Professor of the Practice of Business and Economics, Director of Health Sector Management in the Fuqua School of Business, and a founding faculty member, Duke-Margolis.
Cynthia Binanay, MA, BSN
Senior Project Leader and Director of Operations for the Hubert-Yeargan Center for Global Health
Andrea Thoumi, MSc, MPP
Jonathan Gonzalez-Smith, MPAff
Senior Research Assistant
External Expert Advisor
Nick Chapman, MBBS, MHR, Director of Research at Policy Cures, has agreed to serve in an expert advisory capacity to the Duke team. Dr. Chapman’s experience as a doctor, researcher and analyst with specialty in innovation has established him as a leader in directly applicable fields including product development strategy, gap analysis, and innovative financing of international R&D.
Funding for this project is provided by the following organizations:
The Global Health Technologies Coalition (GHTC) is a group of nearly 30 nonprofit organizations working to increase awareness of the urgent need for technologies that save lives in the developing world. GHTC supports policies and funding that advance research and development for new vaccines, microbicides, drugs, devices, and diagnostics with global health applications. GHTC is housed at PATH within its Advocacy and Public Policy department.
PATH is an international organization that drives transformative innovation to save lives and improve health, especially among women and children. We accelerate innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial approach, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health.